Delray Beach, FL, July 30, 2025 (GLOBE NEWSWIRE) — The global Advanced Wound Care Market, valued at US$12.48 billion in 2024 stood at US$13.37 billion in 2025 and is projected to advance at a resilient CAGR of 7.6% from 2025 to 2030, culminating in a forecasted valuation of US$19.32 billion by the end of the period. This expansion reflects a shift in global healthcare toward value-based wound healing, driven by the growing prevalence of chronic diseases, aging demographics, and rising surgical and trauma cases.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=88705076
What is Driving Market Growth?
The growing need for faster recovery, reduced infection risks, and cost-effective healing outcomes is reshaping how wounds are treated globally. Advanced wound care solutions—such as Negative Pressure Wound Therapy (NPWT), bioactive dressings, and digital wound monitoring tools—are now central to clinical protocols across both acute and chronic care settings.
Who Are the Key Players Shaping the Industry?
Top companies driving innovation, expansion, and consolidation in this space include:
- Solventum (US) – After spinning off from 3M in 2024, Solventum is investing in material science and digital health across wound care.
- Smith+Nephew (UK) – A global leader in NPWT, backed by USD 289M+ in 2024 R&D investment.
- Mölnlycke AB (Sweden) – Expanded via the 2024 acquisition of P.G.F. Industry Solutions, enhancing its Granudacyn wound solutions.
- Other key players: Convatec, Coloplast, Cardinal Health, Integra LifeSciences, Organogenesis, MIMEDX, and Zimmer Biomet.
These companies are focused on R&D-driven differentiation, acquisitions, and global expansion to strengthen market share.
Why is Surgical & Traumatic Wound Care Dominating?
Among wound types, surgical & traumatic wounds captured the largest share in 2024. Why?
- Rising number of surgeries globally
- Increased accidents and injuries
- Need for fast healing, antimicrobial …